Skip to main content
  • Loading metrics

Correction: Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial

  • Xavier Duval,
  • Sylvie van der Werf,
  • Thierry Blanchon,
  • Anne Mosnier,
  • Maude Bouscambert-Duchamp,
  • Annick Tibi,
  • Vincent Enouf,
  • Cécile Charlois-Ou,
  • Corine Vincent,
  • Laurent Andreoletti,
  • Florence Tubach,
  • Bruno Lina,
  • France Mentré,
  • Catherine Leport,
  • and the Bivir Study Group
  • Article
  • Metrics
  • Comments
  • Media Coverage

An error in Figure 1 led to the misrepresentation of the trial design in this figure. The 541 patients enrolled in the study were randomly assigned to three different arms rather than just to a single arm (oseltamivir-zanamivir combination) as suggested by the published figure. - 192 patients were assigned oseltamivir-zanamivir and included in intention to treat analysis - 176 were assigned oseltamivir-placebo and included in intention to treat analysis - 173 were assigned zanamivir-placebo and included in intention to treat analysis See the Corrected Figure 1 via the link below: